Both in Pharmaceuticals
Bristol-Myers Squibb vs Pfizer
Over the past year BMY returned +35.8% and PFE returned +23.8%; their daily moves had a correlation of 0.59.
BMY +35.8% PFE +23.8%Growth of $1, one year, split-adjusted
| Metric | BMY | PFE |
|---|---|---|
| Price | $62.48 | $30.52 |
| Market cap | $127.71B | $173.95B |
| Today | +1.78% | +1.90% |
| 1 month | +1.7% | +8.5% |
| 6 months | +7.3% | +15.9% |
| Year to date | +15.8% | +22.6% |
| 1 year | +46.7% | +25.6% |
| Revenue growth (YoY) | +5.7% | +2.6% |
| Gross margin | 71.3% | 72.8% |
| Net margin | 25.6% | −1.6% |
| P/E (TTM) | 13.8× | 40.2× |
| Price / sales | 2.6× | 2.7× |
| Net cash | -$32.05B | -$51.49B |
| Dividend yield | 4.03% | 5.64% |
| Volatility (60d) | 27.3% | 19.8% |
| Short % of float | 2.4% | 2.4% |
| Next earnings | — | Nov 3, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).